NasdaqGS:IDYABiotechs
IDEAYA Biosciences (IDYA) Is Up 6.3% After Swing to Quarterly Profitability and Revenue Growth - What's Changed
IDEAYA Biosciences, Inc. reported earnings for the third quarter and nine months ended September 30, 2025, showing quarterly revenue of US$207.83 million and net income of US$119.24 million, a turnaround from a net loss in the previous year.
This marks a significant improvement in profitability, with basic earnings per share rising to US$1.35 for the quarter, compared to a loss per share of US$0.60 a year earlier.
We'll explore how returning to quarterly profitability shapes IDEAYA...